New Rett Syndrome Gene Discovered

 The international journal, Neurology, recently published that a research team, jointly run by Australia and Israel, has discovered a genetic mutation that considerably influences the severity of symptoms in Rett syndrome.

The research time is highly optimistic of the discovery insisting that this would open a new avenue in treating the neurological disorder.

So far the medical science was unable to detect the clinical progression of the severity of the symptoms observed in the patients suffering from this disorder. But this new finding will potentially influence it, on the top of it it widens the scope of potential therapy to that effect.

While Rett syndrome is believed to be caused by the mutations in the MECP2 gene, this discovery would define the link between the severity of the symptoms and a common brain-derived neurotrophic factor (BDNF) polymorphism.

As BDNF is greatly responsible in steady function of brain cells, it would be interesting to establish a link between MECP2 and BDNF in future.

As an expert predicts that if BDNF can be stimulated within patience having severity of Rett syndrome, seizures can be delayed and some more types of disorders can be reduced.